Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Oncology Research|May 10, 2000
Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitroM V Papadopoulou, M Ji, S H Khan, et al.
Oncology Research|May 9, 2001
4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive compound as a hypoxia-selective cytotoxinM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|January 1, 1997
9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. IM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|January 1, 1996
9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizerM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|October 9, 2001
4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamineM V Papadopoulou, M Ji, M K Rao, et al.
Oncology Research|January 1, 1994
9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1M V Papadopoulou, H S Rosenzweig, M Doddi, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 20, 1998
Tin shielding thicknesses for electronsS Guru Prasad, K Parthasaradhi, W H Al-Najjar, et al.
Nuclear Medicine and Biology|January 1, 1993
A technique to prepare boronated B72.3 monoclonal antibody for boron neutron capture therapyG N Ranadive, H S Rosenzweig, M W Epperly, et al.
Archives of Gynecology and Obstetrics|January 1, 1989
Diminished corticosterone levels in nude mice implanted with MCF-7 or ZR-75-1 human breast tumor cellsS Lehrer, E Diamond, H K Song, et al.
AJR. American Journal of Roentgenology|October 1, 1976
Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancerP H Sugarbaker, W D Bloomer, E D Corbett, et al.
Pageof 9